New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 12, 2012
16:19 EDTRHHBY, CSCO, MRC, HPQ, ILMN, FIO, FET, AVID, MIPS, OAKOn The Fly: Closing Wrap
Stocks on Wall Street rose significantly on indications from the New York Fed that interest rates will likely remain low. Stock futures were slightly above fair value in early trading but weakened following the slightly disappointing jobless claims data. The futures action led to a relatively quiet open for the market but it soon picked up momentum to the upside. The market moved up roughly 0.5% in early trading, then spurted higher before noon. Investors rallied the market after last night’s comments from Fed president Janet Yellen, who said the Fed should be ready to ease its fiscal stance if the economy weakened while also being willing to raise rates if the economy warranted. Investors grabbed onto the dovish comments and lifted the market for the second day in a row… ECONOMIC EVENTS: In the U.S., 380K initial jobless claims were filed last week, versus the expected 355K. 3.25M continuing claims were reported, versus the expected 3.33M. Producer prices for the month of March were flat, versus the expected increase of 0.3%. The core PPI reading, however, rose 0.3%, versus the expected increase of 0.2%. The trade balance report showed a deficit of $46.0B, versus expectations for a deficit of $51B. In Europe, Italy's short-term borrowing costs rose at auction... COMPANY NEWS: Hewlett-Packard (HPQ) was a beneficiary of two reports from Gartner and IDC, each of which showed that global shipments of personal computers rose in Q1, with HP remaining the top PC maker by volume. On the day, Hewlett-Packard stock was up 7.18% to $25.09… Oaktree Capital (OAK), Forum Energy Technologies (FET) and MRC Global (MRC) all traded for the first time today, though none of the companies' stocks moved much compared to their IPO prices... MAJOR MOVERS: Among the notable gainers were MIPS Technologies (MIPS), which jumped 26.30%, to $6.58, after Bloomberg reported that Goldman Sachs (GS) had been hired to advise it on a possible sale of the company, and Fusion-io (FIO), which rose 14.80%, to $28.31, following a note to investors from Piper Jaffray saying it believes the company is working on a new original equipment manufacturer deal with Cisco (CSCO)… Noteworthy losers included Avid Technology (AVID), which lost 17.32%, to $8.50, after the company announced it expects to post Q1 revenues lower than last year, and Illumina (ILMN), which dropped 5.82%, to $49.51, after Roche Holding’s (RHHBY) CEO said he doesn’t see any reason to raise the current offer for the company… INDICES: The Dow gained 181.19 points, or 1.41%, to 12,986.58; the Nasdaq rose 39.09 points, or 1.30%, to 3,055.55; and the S&P 500 added 18.86 points, or 1.38%, to 1,387.57.
News For HPQ;OAK;FET;MRC;MIPS;FIO;CSCO;AVID;ILMN;RHHBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
February 2, 2016
15:10 EDTRHHBYRoche approached Pacific Biosciences about possible acquisition, Reuters says
14:32 EDTILMNNotable companies reporting after market close
Subscribe for More Information
13:11 EDTILMNIllumina technical comments ahead of earnings
Subscribe for More Information
10:26 EDTCSCOFireEye calls active
Subscribe for More Information
10:18 EDTCSCOCisco could be interested in FireEye, dealReporter says citing sources
Subscribe for More Information
08:36 EDTRHHBYPiper Jaffray biopharma analyst holds an analyst/industry conference call
Subscribe for More Information
05:40 EDTOAKOaktree-backed AdvancePierre picks Barclays for IPO, Bloomberg reports
Subscribe for More Information
February 1, 2016
15:21 EDTILMNIllumina volatility elevated into Q4 and outlook
Illumina February weekly call option implied volatility is at 84, February is at 54, March is at 45; compared to its 52-week range of 22 to 64, suggesting large near term price movement into the expected release of Q4 results on February 2.
11:02 EDTRHHBYRoche: Updated cervical cancer screening guidelines support use of cobas test
Roche announced that recently updated cervical cancer screening guidelines from the American College of Obstetricians and Gynecologists support the use of its cobas HPV Test for primary cervical cancer screening as an alternative to current cytology-based cancer screening methods in women 25 and older. The College's revised Practice Bulletin 157, published in the January issue of Obstetrics & Gynecology, reinforces similar guidance issued in 2015 by the Society for Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology. The cobas HPV Test was approved by the FDA in 2011 for use in screening women 21 and older with unclear Pap test results and for co-testing with a Pap test in women 30 and older. The FDA approved it for first-line primary cervical cancer screening for women 25 and older in April 2014 following a unanimous recommendation from the independent Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee. Currently utilized by more than 250 labs in the U.S., the cobas HPV Test is the only test approved in the U.S. for all three HPV testing options now supported by three major medical societies.
06:33 EDTILMNIllumina signs four biobanking deals
Subscribe for More Information
January 31, 2016
16:13 EDTRHHBYGenentech receives orphan designation for Avastin in mesothelioma
Subscribe for More Information
January 28, 2016
16:50 EDTCSCOCisco says Chief Development Officer Pankaj Patel to step down
Cisco disclosed in a regulatory filing that, on January 25, Pankaj Patel, EVP and Chief Development Officer, Global Engineering of Cisco Systems notified the company of his decision to step down from his current position during 2H16.
15:18 EDTHPQXcel Brands collaborates with HP Inc. to create Isaac Mizrahi smartwatch
Subscribe for More Information
11:18 EDTILMNOptions with increasing put volume
Options with increasing put volume: DRII SNE LH CAVM KSS UCO ILMN JBLU AVT SWK JNPR RRC CL HES
10:05 EDTILMNHigh option volume stocks
Subscribe for More Information
05:48 EDTRHHBYRoche expects 2016 sales to grow low- to mid-single digit
Subscribe for More Information
05:48 EDTRHHBYRoche board recommends dividend increase to CHF 8.10 per share
Subscribe for More Information
05:47 EDTRHHBYRoche reports FY15 core EPS CHF 13.49 vs. CHF 14.29 last year
05:46 EDTRHHBYRoche reports FY15 Group sales CHF 44.15B vs. CHF 47.46B last year
Subscribe for More Information
05:37 EDTRHHBYAbbVie announces venetoclax granted Breakthrough Therapy Designation by FDA
Subscribe for More Information
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use